MannKind Corp
MNKD
#5739
Rank
โ‚น114.75 B
Marketcap
โ‚น356.78
Share price
-2.53%
Change (1 day)
-19.55%
Change (1 year)

EPS for MannKind Corp (MNKD)

EPS in 2026 (TTM): -โ‚น12.19

According to MannKind Corp's latest financial reports the company's current EPS (TTM) is -โ‚น12.05. In 2025 the company made an earnings per share (EPS) of โ‚น1.85 a decrease over its 2024 EPS that were of โ‚น9.27.

EPS history for MannKind Corp from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น12.19-757.85%
2025โ‚น1.85-80%
2024โ‚น9.27
2022-โ‚น31.516.25%
2021-โ‚น29.6528%
2020-โ‚น23.17-7.41%
2019-โ‚น25.02
2017-โ‚น102.86-188.1%
2016โ‚น116.76-128.31%
2015-โ‚น412.3874.51%
2014-โ‚น236.31-20.31%
2013-โ‚น296.54-32.63%
2012-โ‚น440.18-28.03%
2011-โ‚น611.62

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น65.80-646.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
โ‚น365.66-3,135.27%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Eli Lilly
LLY
โ‚น2,863-23,862.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น92.03-863.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
โ‚น326.20-2,807.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
-โ‚น620.89 5,053.85%๐Ÿ‡บ๐Ÿ‡ธ USA